Dear Colleague:
We are pleased to bring you our 2019 Report on Clinical and Scientific Innovations in Neurology and Neurosurgery. The Departments of Neurology and Neurosurgery at NewYork-Presbyterian continue to lead in the diagnosis and treatment of neurological diseases and disorders, with nationally and internationally recognized faculty practicing at the forefront of their specialties. Their efforts are strengthened and supported by the exceptional clinical, scientific, and educational resources made possible by NewYork-Presbyterian’s affiliation with two renowned medical schools – Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine. Our vast academic medical enterprise affords our physicians and surgeons important opportunities for conducting research that, in turn, drives progress in neurological and neurosurgical care.
In this year’s report, we present work that is underway in glioblastoma, one of the deadliest forms of cancer. At the basic science level, our researchers continue their investigations to better understand the role of genetics in Alzheimer’s disease. We also include updates on new applications for high-intensity focused ultrasound for an expanding range of conditions, as well as the latest treatments for complex epilepsy cases. In addition, our efforts in helping patients with debilitating spinal disease are highlighted.
NewYork-Presbyterian is proud to be a destination of choice for patients who seek out our expertise and experience in neurology and neurosurgery from the metropolitan area, across the country, and around the world. We are committed to continue pursuing progress in the labs and at the bedside to achieve the best possible outcomes and quality of life for our patients.